Cargando…
The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
The lack of curative options for pulmonary arterial hypertension drives important research to understand the mechanisms underlying this devastating disease. Among the main identified pathways, the platelet-derived growth factor (PDGF) pathway was established to control vascular remodeling and anti-P...
Autores principales: | Solinc, Julien, Ribot, Jonathan, Soubrier, Florent, Pavoine, Catherine, Dierick, France, Nadaud, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143262/ https://www.ncbi.nlm.nih.gov/pubmed/35629326 http://dx.doi.org/10.3390/life12050658 |
Ejemplares similares
-
Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension
por: Dierick, France, et al.
Publicado: (2021) -
Platelet‐Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension
por: Solinc, Julien, et al.
Publicado: (2022) -
Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages
por: Besse, Sophie, et al.
Publicado: (2022) -
Genetics and genomics of pulmonary arterial hypertension
por: Morrell, Nicholas W., et al.
Publicado: (2019) -
Transcriptomic and Lipidomic Mapping of Macrophages in the Hub of Chronic Beta-Adrenergic-Stimulation Unravels Hypertrophy-, Proliferation-, and Lipid Metabolism-Related Genes as Novel Potential Markers of Early Hypertrophy or Heart Failure
por: Nadaud, Sophie, et al.
Publicado: (2022)